Part, Chapter, Paragraph
1 -, 1 | information to facilitate the identification of priority issues for future
2 I, 2.Acr | Genomics~RFID~Radio Frequency Identification~SMEs~Small and medium-sized
3 I, 2. 10. 3| debate on radio frequency identification (RFID) and issuing of policy
4 I, 2. 10. 4| 2.10.4. Automatic identification and traceability technologies~ ~
5 I, 2. 10. 4| bar-codes or radio frequency identification (RFID) allow automatic identification
6 I, 2. 10. 4| identification (RFID) allow automatic identification and data capture of pharmaceutical
7 I, 2. 10. 4| a lower cost than manual identification alone.~ ~Automatic identification
8 I, 2. 10. 4| identification alone.~ ~Automatic identification systems have a very wide
9 I, 2. 10. 4| make also feasible a unique identification for each and every pack
10 I, 2. 10. 4| have shown that automatic identification throughout the entire Healthcare
11 I, 2. 10. 4| introduction of a unique identification for drugs or medical device,
12 I, 2. 10. 4| consumption. This unique identification can then be crosschecked
13 I, 2. 10. 4| of all need a legitimate identification number that is registered
14 I, 2. 10. 4| hospital budgets18.~ ~Automatic identification and traceability systems
15 I, 2. 10. 4| process and automatic product identification in the San Raffaele Scientific
16 I, 2. 10. 4| availability of automatic identification systems in hospitals today
17 I, 2. 10. 4| penetration of automatic identification technologies is higher with
18 I, 2. 10. 4| necessary for automatic identification until manufacturers routinely
19 I, 2. 10. 4| benefits related to automatic identification and traceability systems.
20 I, 2. 10. 4| border trading, a global identification number can be used to identify
21 I, 2. 10. 4| various local requirements. Identification numbering schemes developed
22 I, 2. 10. 4| increase significantly. Identification numbering should be as ubiquitous
23 I, 2. 10. 4| settings, such as patient identification codes on wristbands.” 22~ ~
24 II, 5. 1. 1| policies. Screening and case identification strategies allow, in some
25 II, 5. 3. 7| linked chain of actions, from identification and invitation of the target
26 II, 5. 3. 7| survival rates allows the identification of regions or countries
27 II, 5. 4. 2| Plans for the prevention, identification and treatment of diabetes
28 II, 5. 4. 2| specific national unique identification numbers, including the use
29 II, 5. 4. 2| register, through a central identification number that can be used
30 II, 5. 5. 3| and tries to get a better identification of adolescents at risk of
31 II, 5. 5. 3| is represented by early identification and intervention with the
32 II, 5. 5. 3| Prevention through Risk Identification, Management, and Education (
33 II, 5. 5. 3| State in ASD as the case identification system is very weak and
34 II, 5. 5. 3| of two or three. Earlier identification of children with ASD could
35 II, 5. 5. 3| risk, the extent of case identification and the study design.~ ~
36 II, 5. 7. 7| 461-70.~Levin A (2001): Identification of patients and risk factors
37 II, 5. 9. FB| requires a more precise identification of atopic individuals, even
38 II, 5. 9. 5| requires a more precise identification of atopic individuals, even
39 II, 5. 11. 3| young people themselves.~The identification of new metals as significant
40 II, 5. 12. 6| transplantation is performed after identification and diagnosis of liver cancer
41 II, 5. 14. 6| Europe, thus complicating the identification of these groups and the
42 II, 5. 15. 3| causes the disease. The identification of at risk couples is hardly
43 II, 5. 15. 4| improvement of knowledge and identification of RD; improvement of diagnosis
44 II, 7. 3. 4| of road accidents for the identification and quantification of road
45 II, 7. 3. 4| Home and leisure~ ~The identification of home and leisure accidents
46 II, 7. 4 | reduction.~ ~This has led to the identification of the following seven priority
47 II, 8. 2. 1| associated with access to care, identification of disease and treatment
48 II, 8. 2. 1| or fragile X syndrome. Identification of a gene for an inherited
49 II, 9. 2. 4| more important – is the identification of the relative importance
50 II, 9. 2. 6| primary care to seek improved identification and measurement of the problem.~ ~
51 II, 9. 3. 2| A key challenge is the identification of meaningful indicators
52 II, 9. 5. 4| for further research. The identification and measurement of health-damaging
53 III, 10. 2. 4| earlier and more precise identification of risk strata in families
54 III, 10. 2. 4| the population (i.e., the identification of high, moderate and low
55 III, 10. 2. 5| childhood and adult health. Identification of early developmental factors
56 III, 10. 3. 1| Additionally, diagnosis and case identification may be more common in this
57 III, 10. 3. 1| preventive activities and the identification of core issues of concern.
58 III, 10. 4. 2| crucial areas;~· inadequate identification of emerging risks; and~·
59 III, 10. 4. 2| considered as provisional.~ ~The identification of the origin of feed and
60 III, 10. 4. 2| Europe, QPS will permit the identification of what is required to make
61 III, 10. 4. 2| analysis of foods” and for “the identification of “emerging risks”~ ~Risk-benefit
62 III, 10. 4. 2| following steps:~ ~· The hazard identification describes the adverse effects
63 III, 10. 4. 2| assessment should include benefit identification, benefit characterisation (
64 III, 10. 4. 2| procedure for emerging risks identification is being worked out by EFSA
65 III, 10. 4. 5| data are available, site identification activities are generally
66 III, 10. 5. 2| of monitoring and reduced identification (thereby leading to an under-reporting
67 III, 10. 5. 3| equipment~- 90/269/EEC: identification and prevention of manual
68 III, 10. 5. 3| machinery~- 2002/44/EC: identification and prevention of risks
69 IV, 12. 5 | assessment by promoting the early identification of risks; analyse their
70 IV, 13. 7. 5| policies through a better identification of risk groups. Recent technical